PerkinElmer open to more 'informatics' buyouts; Euerka Genomics snags $750K SBIR grant;

> Eureka Genomics, a provider of bioinformatics analysis, has snagged a two-year, $750,000 Small Business Innovation Research grant from the Department of Homeland Security to develop tools for use in finding rare variants of the anthrax pathogen, Bacillus anthracis. Release

> PerkinElmer ($PKI) CEO Rob Friel still has an appetite for buying "informatics" companies. Item

> Second Genome, a start-up that uses a proprietary assay and bioinformatics to study microbes, has brought in $5 million from investors. Report

> Stakeholders in The Netherlands have grown a national network for reporting medication errors. Abstract

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.